Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Yibai Women's Pharmaceutical is a specialized subsidiary of the publicly traded Guizhou Yibai Pharmaceutical Co., Ltd., focusing on the research, development, and manufacturing of gynecological medicines. The company primarily utilizes Traditional Chinese Medicine (TCM) principles to produce a variety of treatments for women's health issues, including menstrual irregularities and inflammatory conditions. Its flagship products, such as Fuke Zaiqing Pills, are widely recognized in the Chinese domestic market for their efficacy in treating chronic gynecological ailments. Operating modern manufacturing facilities that comply with national GMP standards, the company plays a critical role in its parent group's strategy to dominate specialized therapeutic segments. The firm is headquartered in Guiyang, Guizhou province, and remains a key player in the modernization of traditional herbal therapies for women.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Yibai Women's Pharmaceutical.